Surgical treatment of multiple breast cancer brain metastases: clinical characteristics and factors impacting postoperative survival - Top-Institutions - MDSpire

Surgical treatment of multiple breast cancer brain metastases: clinical characteristics and factors impacting postoperative survival

  • By

  • Anna Michel

  • Laurèl Rauschenbach

  • Hanah Karadachi

  • Meltem Gümüs

  • Yahya Ahmadipour

  • Marvin Darkwah Oppong

  • Christoph Pöttgen

  • Jörg Hense

  • Neriman Özkan

  • Karsten H. Wrede

  • Philipp Dammann

  • Ulrich Sure

  • Ramazan Jabbarli

  • April 29, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neurosurgery
    • Medical Oncology
    • Radiation Oncology
    • Neuro-oncology

  • #2

    Dana-Farber Cancer Institute / Brigham and Women’s Hospital
    Dana-Farber Cancer Institute / Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Neurosurgery
    • Radiation Oncology
    • Neuro-oncology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Neurosurgery
    • Medical Oncology
    • Radiation Oncology
    • Neuro-oncology

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neurosurgery
    • Medical Oncology
    • Radiation Oncology
    • Neuro-oncology

  • #5

    University Hospital Essen
    University Hospital Essen

    Essen, North Rhine-Westphalia

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Breast Cancer Surgery

Original Source(s)

Surgical treatment of multiple breast cancer brain metastases: clinical characteristics and factors impacting postoperative survival

  • by Anna Michel, Laurèl Rauschenbach, Hanah Karadachi, Meltem Gümüs, Yahya Ahmadipour, Marvin Darkwah Oppong, Christoph Pöttgen, Jörg Hense, Neriman Özkan, Karsten H. Wrede, Philipp Dammann, Ulrich Sure, Ramazan Jabbarli

  • April 29, 2025

Related Content

Should checkpoint inhibitors be reserved for biomarker-selected pediatric brain tumors?

Multi-parametric MRI habitat radiomics with interpretable machine learning for early prediction of axillary lymph node metastasis in triple-negative breast cancer

Comparison of the diagnostic power of serum circulating miR-21, VEGF, and CA15-3 in breast cancer